KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Cash from Restructuring (2018 - 2019)

Historic Cash from Restructuring for Arbutus Biopharma (ABUS) over the last 2 years, with Q4 2019 value amounting to -$66000.0.

  • Arbutus Biopharma's Cash from Restructuring fell 11176.47% to -$66000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was -$983000.0, marking a year-over-year decrease of 15903.9%. This contributed to the annual value of -$983000.0 for FY2019, which is 17385.42% down from last year.
  • According to the latest figures from Q4 2019, Arbutus Biopharma's Cash from Restructuring is -$66000.0, which was down 11176.47% from -$138000.0 recorded in Q3 2019.
  • In the past 5 years, Arbutus Biopharma's Cash from Restructuring ranged from a high of $1.0 million in Q1 2018 and a low of -$640000.0 during Q2 2019